Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 523

1.

Contractile dysfunction and nitrergic dysregulation in small intestine of a primate model of Parkinson's disease.

Coletto E, Dolan JS, Pritchard S, Gant A, Hikima A, Jackson MJ, Benham CD, Chaudhuri KR, Rose S, Jenner P, Iravani MM.

NPJ Parkinsons Dis. 2019 Jun 10;5:10. doi: 10.1038/s41531-019-0081-9. eCollection 2019.

2.

Investigation and surgical treatment of a superior vena cava lipoma.

Beliaev AM, Bergin C, Hill AA, Chaudhuri K, Haydock DA.

ANZ J Surg. 2019 Jun 23. doi: 10.1111/ans.15313. [Epub ahead of print] No abstract available.

PMID:
31230421
3.

Oral submucous fibrosis: A global challenge. Rising incidence, risk factors, management, and research priorities.

Ray JG, Chatterjee R, Chaudhuri K.

Periodontol 2000. 2019 Jun;80(1):200-212. doi: 10.1111/prd.12277. Review.

PMID:
31090137
4.

Barriers to reporting non-motor symptoms to health-care providers in people with Parkinson's.

Hurt CS, Rixon L, Chaudhuri KR, Moss-Morris R, Samuel M, Brown RG.

Parkinsonism Relat Disord. 2019 Apr 20. pii: S1353-8020(19)30209-3. doi: 10.1016/j.parkreldis.2019.04.014. [Epub ahead of print]

PMID:
31036430
5.

Aggregation-Induced Emission-Based Sensing Platform for Selective Detection of Zn2+ : Experimental and Theoretical Investigations.

Naskar B, Dhara A, Maiti DK, Kukułka M, Mitoraj MP, Srebro-Hooper M, Prodhan C, Chaudhuri K, Goswami S.

Chemphyschem. 2019 Jun 17;20(12):1630-1639. doi: 10.1002/cphc.201900113. Epub 2019 Jun 4.

PMID:
30983076
6.

Should there be less emphasis on levodopa-induced dyskinesia in Parkinson's disease?

Chaudhuri KR, Jenner P, Antonini A.

Mov Disord. 2019 Jun;34(6):816-819. doi: 10.1002/mds.27691. Epub 2019 Apr 14. No abstract available.

PMID:
30983023
7.

Pilot Study of the International Parkinson and Movement Disorder Society-sponsored Non-motor Rating Scale (MDS-NMS).

Martinez-Martin P, Schrag A, Weintraub D, Rizos A, Rodriguez-Blazquez C, Chaudhuri KR; IPMDS Non Motor PD Study Group.

Mov Disord Clin Pract. 2019 Feb 5;6(3):227-234. doi: 10.1002/mdc3.12728. eCollection 2019 Mar.

PMID:
30949554
8.

Slave to the rhythm: Seasonal differences in non-motor symptoms in Parkinson's disease.

van Wamelen DJ, Podlewska AM, Leta V, Śmiłowska K, Rizos A, Martinez-Martin P, Bloem BR, Chaudhuri KR.

Parkinsonism Relat Disord. 2019 Jun;63:73-76. doi: 10.1016/j.parkreldis.2019.02.041. Epub 2019 Feb 28.

PMID:
30867088
9.

A quick accelerating microwave-assisted sustainable technique: permutated spiro-casing for imaging experiment.

Mondal A, Naskar B, Goswami S, Prodhan C, Chaudhuri K, Mukhopadhyay C.

Mol Divers. 2019 Mar 6. doi: 10.1007/s11030-019-09934-7. [Epub ahead of print]

PMID:
30843126
10.

Relationship of Nocturnal Sleep Dysfunction and Pain Subtypes in Parkinson's Disease.

Martinez-Martin P, Rizos AM, Wetmore JB, Antonini A, Odin P, Pal S, Sophia R, Carroll C, Martino D, Falup-Pecurariu C, Kessel B, Andrews T, Paviour D, Trenkwalder C, Chaudhuri KR; EUROPAR & MDS Non‐Motor PD Study Group.

Mov Disord Clin Pract. 2018 Nov 8;6(1):57-64. doi: 10.1002/mdc3.12694. eCollection 2019 Jan.

PMID:
30746417
11.

Solvent-Dependent Nanostructures Based on Active π-Aggregation Induced Emission Enhancement of New Carbazole Derivatives of Triphenylacrylonitrile.

Maity S, Aich K, Prodhan C, Chaudhuri K, Pramanik AK, Das S, Ganguly J.

Chemistry. 2019 Mar 27;25(18):4856-4863. doi: 10.1002/chem.201900312. Epub 2019 Mar 8.

PMID:
30693577
12.

Dietary Variations in a Multiethnic Parkinson's Disease Cohort and Possible Influences on Nonmotor Aspects: A Cross-Sectional Multicentre Study.

Sauerbier A, Schrag A, Martinez-Martin P, Hall LJ, Parry M, Mischley LK, Zis P, Chaudhuri KR.

Parkinsons Dis. 2018 Dec 18;2018:7274085. doi: 10.1155/2018/7274085. eCollection 2018.

13.

Continuous Drug Delivery Aiming Continuous Dopaminergic Stimulation in Parkinson's Disease.

van Wamelen DJ, Grigoriou S, Chaudhuri KR, Odin P.

J Parkinsons Dis. 2018;8(s1):S65-S72. doi: 10.3233/JPD-181476.

14.

Liquid biopsy: miRNA as a potential biomarker in oral cancer.

Mazumder S, Datta S, Ray JG, Chaudhuri K, Chatterjee R.

Cancer Epidemiol. 2019 Feb;58:137-145. doi: 10.1016/j.canep.2018.12.008. Epub 2018 Dec 19. Review.

PMID:
30579238
15.

Levodopa-carbidopa intestinal gel in a subgroup of patients with dyskinesia at baseline from the GLORIA Registry.

Poewe W, Chaudhuri KR, Bergmann L, Antonini A.

Neurodegener Dis Manag. 2019 Feb;9(1):39-46. doi: 10.2217/nmt-2018-0034. Epub 2018 Dec 14.

16.

Management Recommendations on Sleep Disturbance of Patients with Parkinson's Disease.

Liu CF, Wang T, Zhan SQ, Geng DQ, Wang J, Liu J, Shang HF, Wang LJ, Chan P, Chen HB, Chen SD, Wang YP, Zhao ZX, Chaudhuri KR.

Chin Med J (Engl). 2018 Dec 20;131(24):2976-2985. doi: 10.4103/0366-6999.247210. No abstract available.

17.

Evaluation of nocturnal hypokinesia in Parkinson's disease using a novel patient/proxy questionnaire and correlations with objective monitoring.

Bhidayasiri R, Phokaewvarangkul O, Sringean J, Martinez-Martin P, Anan C, Kantachadvanich N, Chaudhuri KR, Hattori N.

Parkinsonism Relat Disord. 2019 Apr;61:219-223. doi: 10.1016/j.parkreldis.2018.09.023. Epub 2018 Sep 21.

PMID:
30314847
18.

Dihydroindeno[1,2-b]pyrroles: new Al3+ selective off-on chemosensors for bio-imaging in living HepG2 cells.

Mal K, Naskar B, Mondal A, Goswami S, Prodhan C, Chaudhuri K, Mukhopadhyay C.

Org Biomol Chem. 2018 Aug 15;16(32):5920-5931. doi: 10.1039/c8ob01411f.

PMID:
30074036
19.

Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial.

Katzenschlager R, Poewe W, Rascol O, Trenkwalder C, Deuschl G, Chaudhuri KR, Henriksen T, van Laar T, Spivey K, Vel S, Staines H, Lees A.

Lancet Neurol. 2018 Sep;17(9):749-759. doi: 10.1016/S1474-4422(18)30239-4. Epub 2018 Jul 25.

PMID:
30055903
20.

Assessment and Management of Neuropsychiatric Symptoms in Parkinson's Disease.

Mueller C, Rajkumar AP, Wan YM, Velayudhan L, Ffytche D, Chaudhuri KR, Aarsland D.

CNS Drugs. 2018 Jul;32(7):621-635. doi: 10.1007/s40263-018-0540-6.

PMID:
30027401
21.

Noninvasive options for 'wearing-off' in Parkinson's disease: a clinical consensus from a panel of UK Parkinson's disease specialists.

Fackrell R, Carroll CB, Grosset DG, Mohamed B, Reddy P, Parry M, Chaudhuri KR, Foltynie T.

Neurodegener Dis Manag. 2018 Oct;8(5):349-360. doi: 10.2217/nmt-2018-0020. Epub 2018 Jul 5.

22.

A noninterventional study evaluating the effectiveness of rotigotine and levodopa combination therapy in younger versus older patients with Parkinson's disease.

Woitalla D, Dunac A, Safavi A, Ceravolo MG, Gomez Esteban JC, Pavese N, Asgharnejad M, Joeres L, Schuller JC, Chaudhuri KR.

Expert Opin Pharmacother. 2018 Jun;19(9):937-945. doi: 10.1080/14656566.2018.1480721. Epub 2018 Jun 19.

PMID:
29916262
23.

A detailed clinical study of pain in 1957 participants with early/moderate Parkinson's disease.

Silverdale MA, Kobylecki C, Kass-Iliyya L, Martinez-Martin P, Lawton M, Cotterill S, Chaudhuri KR, Morris H, Baig F, Williams N, Hubbard L, Hu MT, Grosset DG; UK Parkinson's Pain Study Collaboration.

Parkinsonism Relat Disord. 2018 Nov;56:27-32. doi: 10.1016/j.parkreldis.2018.06.001. Epub 2018 Jun 6.

24.

Exploring Bedroom Usability and Accessibility in Parkinson's Disease (PD): The Utility of a PD Home Safety Questionnaire and Implications for Adaptations.

Bhidayasiri R, Jitkritsadakul O, Sringean J, Jantanapornchai T, Kantachadvanich N, Phumphid S, Boonpang K, Pensook S, Aungkab N, Hattori N, Chaudhuri KR.

Front Neurol. 2018 May 17;9:360. doi: 10.3389/fneur.2018.00360. eCollection 2018.

25.

Changes in Parkinson's disease sleep symptoms and daytime somnolence after bilateral subthalamic deep brain stimulation in Parkinson's disease.

Kharkar S, Ellenbogen JR, Samuel M, Rizos A, Silverdale M, Chaudhuri KR, Ashkan K.

NPJ Parkinsons Dis. 2018 May 25;4:16. doi: 10.1038/s41531-018-0053-5. eCollection 2018.

26.

Serotonergic dysregulation is linked to sleep problems in Parkinson's disease.

Wilson H, Giordano B, Turkheimer FE, Chaudhuri KR, Politis M.

Neuroimage Clin. 2018 Mar 2;18:630-637. doi: 10.1016/j.nicl.2018.03.001. eCollection 2018.

27.

First comprehensive tool for screening pain in Parkinson's disease: the King's Parkinson's Disease Pain Questionnaire.

Martinez-Martin P, Rizos AM, Wetmore J, Antonini A, Odin P, Pal S, Sophia R, Carroll C, Martino D, Falup-Pecurariu C, Kessel B, Andrews T, Paviour D, Trenkwalder C, Chaudhuri KR; EUROPAR and MDS Non-motor PD Study Group.

Eur J Neurol. 2018 Oct;25(10):1255-1261. doi: 10.1111/ene.13691. Epub 2018 Jun 22.

PMID:
29806962
28.

Characterization of a fluorescent hydrogel synthesized using chitosan, polyvinyl alcohol and 9-anthraldehyde for the selective detection and discrimination of trace Fe3+ and Fe2+ in water for live-cell imaging.

Maity S, Parshi N, Prodhan C, Chaudhuri K, Ganguly J.

Carbohydr Polym. 2018 Aug 1;193:119-128. doi: 10.1016/j.carbpol.2018.03.073. Epub 2018 Mar 27.

PMID:
29773363
29.

Non-motor Parkinson disease: new concepts and personalised management.

Titova N, Chaudhuri KR.

Med J Aust. 2018 May 21;208(9):404-409. Review.

PMID:
29764353
30.

Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson's disease.

Odin P, Chaudhuri KR, Volkmann J, Antonini A, Storch A, Dietrichs E, Pirtošek Z, Henriksen T, Horne M, Devos D, Bergquist F.

NPJ Parkinsons Dis. 2018 May 10;4:14. doi: 10.1038/s41531-018-0051-7. eCollection 2018. Review.

31.

Salivary levels of TNF-α in patients with recurrent aphthous stomatitis: A cross-sectional study.

Chaudhuri K, Nair KK, Ashok L.

J Dent Res Dent Clin Dent Prospects. 2018 Winter;12(1):45-48. doi: 10.15171/joddd.2018.007. Epub 2018 Mar 14.

32.

Pain in Parkinson's disease: facts and uncertainties.

Antonini A, Tinazzi M, Abbruzzese G, Berardelli A, Chaudhuri KR, Defazio G, Ferreira J, Martinez-Martin P, Trenkwalder C, Rascol O.

Eur J Neurol. 2018 Jul;25(7):917-e69. doi: 10.1111/ene.13624. Epub 2018 Apr 18. Review.

PMID:
29520899
33.

A hydrazone based probe for selective sensing of Al(iii) and Al(iii)-probe complex mediated secondary sensing of PPi: framing of molecular logic circuit and memory device and computational studies.

Mohammad H, Islam ASM, Prodhan C, Chaudhuri K, Ali M.

Photochem Photobiol Sci. 2018 Feb 14;17(2):200-212. doi: 10.1039/c7pp00286f.

PMID:
29260186
34.

I2 catalyzed access of spiro[indoline-3,4'-pyridine] appended amine dyad: new ON-OFF chemosensors for Cu2+ and imaging in living cells.

Mondal A, Naskar B, Goswami S, Prodhan C, Chaudhuri K, Mukhopadhyay C.

Org Biomol Chem. 2018 Jan 3;16(2):302-315. doi: 10.1039/c7ob02651j.

PMID:
29243763
35.

Non motor symptoms in progressive supranuclear palsy: prevalence and severity.

Radicati FG, Martinez Martin P, Fossati C, Chaudhuri KR, Torti M, Rodriguez Blazquez C, Vacca L, Stocchi F.

NPJ Parkinsons Dis. 2017 Dec 8;3:35. doi: 10.1038/s41531-017-0037-x. eCollection 2017.

36.

The Parkinson's Disease Composite Scale: results of the first validation study.

Stocchi F, Radicati FG, Chaudhuri KR, Johansson A, Padmakumar C, Falup-Pecurariu C, Martinez-Martin P.

Eur J Neurol. 2018 Mar;25(3):503-511. doi: 10.1111/ene.13529. Epub 2018 Jan 13.

PMID:
29193455
37.

Erratum: Author Correction: Using a smartphone-based self-management platform to support medication adherence and clinical consultation in Parkinson's disease.

Lakshminarayana R, Wang D, Burn D, Chaudhuri KR, Galtrey C, Guzman NV, Hellman B, James B, Pal S, Stamford J, Steiger M, Stott RW, Teo J, Barker RA, Wang E, Bloem BR, van der Eijk M, Rochester L, Williams A.

NPJ Parkinsons Dis. 2017 Nov 13;3:32. doi: 10.1038/s41531-017-0034-0. eCollection 2017.

38.

Advanced Parkinson's or "complex phase" Parkinson's disease? Re-evaluation is needed.

Titova N, Martinez-Martin P, Katunina E, Chaudhuri KR.

J Neural Transm (Vienna). 2017 Dec;124(12):1529-1537. doi: 10.1007/s00702-017-1799-3. Epub 2017 Nov 7. Review.

39.

Management of Psychosis in Parkinson's Disease: Emphasizing Clinical Subtypes and Pathophysiological Mechanisms of the Condition.

Taddei RN, Cankaya S, Dhaliwal S, Chaudhuri KR.

Parkinsons Dis. 2017;2017:3256542. doi: 10.1155/2017/3256542. Epub 2017 Sep 12. Review.

40.

Constipation is not associated with dopamine transporter pathology in early drug-naïve patients with Parkinson's disease.

Pagano G, Yousaf T, Wilson H, Niccolini F, Polychronis S, Chaudhuri KR, Politis M.

Eur J Neurol. 2018 Feb;25(2):307-312. doi: 10.1111/ene.13503. Epub 2017 Dec 11.

PMID:
29078029
41.

Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry.

Antonini A, Poewe W, Chaudhuri KR, Jech R, Pickut B, Pirtošek Z, Szasz J, Valldeoriola F, Winkler C, Bergmann L, Yegin A, Onuk K, Barch D, Odin P; GLORIA study co-investigators.

Parkinsonism Relat Disord. 2017 Dec;45:13-20. doi: 10.1016/j.parkreldis.2017.09.018. Epub 2017 Sep 22.

42.

Identification of over expressed proteins in oral submucous fibrosis by proteomic analysis.

Das T, Prodhan C, Patsa S, Ray JG, Chaudhuri K.

J Cell Biochem. 2018 Jun;119(6):4361-4371. doi: 10.1002/jcb.26423. Epub 2018 Feb 28.

PMID:
28980718
43.

Parkinson's Disease Subtypes Identified from Cluster Analysis of Motor and Non-motor Symptoms.

Mu J, Chaudhuri KR, Bielza C, de Pedro-Cuesta J, Larrañaga P, Martinez-Martin P.

Front Aging Neurosci. 2017 Sep 20;9:301. doi: 10.3389/fnagi.2017.00301. eCollection 2017.

44.

The cost-effectiveness of levodopa/carbidopa intestinal gel compared to standard care in advanced Parkinson's disease.

Lowin J, Sail K, Baj R, Jalundhwala YJ, Marshall TS, Konwea H, Chaudhuri KR.

J Med Econ. 2017 Nov;20(11):1207-1215. doi: 10.1080/13696998.2017.1379411. Epub 2017 Sep 21.

PMID:
28895769
45.

Estimation of Serum Butyryl Cholinesterase in Patients with Oral Squamous Cell Carcinoma: A Cross-Sectional Study.

Nair KK, Pramod GV, Chaudhuri K, Ashok L.

J Clin Diagn Res. 2017 Jul;11(7):ZC59-ZC62. doi: 10.7860/JCDR/2017/27127.10207. Epub 2017 Jul 1.

46.

Rotigotine transdermal patch and sleep in Parkinson's disease: where are we now?

Rosa-Grilo M, Qamar MA, Taddei RN, Pagonabarraga J, Kulisevsky J, Sauerbier A, Chaudhuri KR.

NPJ Parkinsons Dis. 2017 Sep 5;3:28. doi: 10.1038/s41531-017-0030-4. eCollection 2017. Review.

47.

Intense 18F-FDG uptake in an organizing right atrial thrombus mimicking malignancy.

Chaudhuri KG, Revels JW, Yadwadkar KS, Johnson LS.

Radiol Case Rep. 2017 Jun 10;12(3):449-454. doi: 10.1016/j.radcr.2017.04.023. eCollection 2017 Sep.

48.

Aggressive fibromatosis of the oral cavity in a 5 year old boy: a rare case report.

Nair KK, Chaudhuri K, Lingappa A, Shetty R, Vittobarao PG.

Pan Afr Med J. 2017 May 18;27:47. doi: 10.11604/pamj.2017.27.47.11739. eCollection 2017.

49.

Identifying barriers to help-seeking for non-motor symptoms in people with Parkinson's disease.

Hurt CS, Rixon L, Chaudhuri KR, Moss-Morris R, Samuel M, Brown RG.

J Health Psychol. 2019 Apr;24(5):561-571. doi: 10.1177/1359105316683239. Epub 2016 Dec 1.

PMID:
28810364
50.

Nonmotor Parkinson's and Future Directions.

Titova N, Chaudhuri KR.

Int Rev Neurobiol. 2017;134:1493-1505. doi: 10.1016/bs.irn.2017.05.017. Epub 2017 Jul 4. Review.

PMID:
28805581

Supplemental Content

Loading ...
Support Center